Dr. Mikhail Blagokslonny is a professor and researcher at the Roswell Park Cancer Institute in New York. As a Professor he teaches students about the field of Oncology in the Department of Cell Stress Biology. His research is primarily focused on discovering effective cancer treatments as well as research into anti-aging therapies. He earned both his PhD and M.D. at the First Pavlov State Medical University of St. Peterburg where he graduated with degrees in cardiology and experimental medicine. His specialties as a scientist are in Oncology, Hematology, and performing clinical trials. Follow Mikhail on Google Scholar
Dr. Blagosklonny has heavily researched the cancer drug rapamycin and how it could be a key to anti-aging. He has tested his hypothesis about how rapamycin extends life as it inhibits TOR signaling which regulates cell growth and metabolism. He is known in the field of medicine as one of the strongest advocates of using rapamycin in longevity research. Among his many research papers he has also created the hyper-function theory of aging in which he hypothesizes that aging is the result of an accumulation of molecular damage.
There are a number of peer-reviewed journals that Dr. Mikhail Blagosklonny is the editor-in-chief of. These journals include Oncotarget, Cell Cycle, and Aging. He is also the editor of Cell Death & Differentiation and the associate editor of Cancer Biology & Therapy, Cancer Biology & Therapy, Autophagy, International Journal of Cancer, and other medical journals. Mikhail Blagosklonny has also written over 300 research papers, book chapters, and reviews himself. His research has generated over 25,000 citations in other research papers.
Check Mikhail’s profile in LinkedIn